| ViraEpi821 | Epstein barr virus (EBV) | Wp | NA | 13956 | 13956 | Hypo | 33.33% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi822 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Hypo | 16.66% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi823 | Epstein barr virus (EBV) | Wp | NA | 14015 | 14015 | Hypo | 8.33% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi829 | Epstein barr virus (EBV) | Wp | NA | 14115 | 14115 | Hypo | 33.33% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi830 | Epstein barr virus (EBV) | Wp | NA | 14143 | 14143 | Hypo | 16.66% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi831 | Epstein barr virus (EBV) | Wp | NA | 14161 | 14161 | Hypo | 33.33% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi837 | Epstein barr virus (EBV) | Wp | NA | 14381 | 14381 | Hypo | 8.33% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi838 | Epstein barr virus (EBV) | Wp | NA | 14391 | 14391 | Hypo | 16.66% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi857 | Epstein barr virus (EBV) | Wp | NA | 14381 | 14381 | Hypo | 36.36% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 |